Close
CDMO Safety Testing 2026
Novotech

Antibodies com Raises 400000 Pre Seed Round to Help Researchers Discover More For Less

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...

Cantex and Headlamp Target MS Depression Using Lumos AI

Cantex Pharmaceuticals and Headlamp Health have entered a collaboration...

VoxCell and adMare Partner on Antibody Therapy Research

VoxCell BioInnovation Inc. and adMare BioInnovations have entered a...
- Advertisement -

Antibodies.com, a digital marketplace that enables life scientists to purchase critical research reagents at cost-effective prices from the primary manufacturers, announced that is has raised £400,000 in pre-seed financing. Nidobirds Ventures, after successful investment in Labstep, joined local angel investors and industry veterans in the funding round. The funds will be used by Antibodies.com to expand its catalogue of off-the-shelf reagents, implement new sales and marketing programs to drive customer acquisition, and scale its proprietary AI assisted “Product Matching” tool.

Antibodies.com enables researchers to source reliable antibodies, proteins, and immunoassays up to 5x faster and 75% cheaper than current methods. This is especially important as roughly 50% of research antibodies simply don’t work in experiments; this wastes billions of dollars of funding and countless hours each year, ultimately: slowing down studies, wasting research samples, and delaying treatments from getting to patients.

The company launched out of beta in May 2018 and has since gone from strength to strength. Antibodies.com now works with 50+ supply chain partners, offers 70,000+ research reagents, and operates across North America and Europe. Customers now include some of the world’s largest pharmaceutical companies (including Glaxo Smith Kline, Glenmark Pharmaceuticals, and Merck & Co) and leading academic research institutions (including MIT, Standard University, University of Cambridge, and University of Oxford).

“Today’s fundraise is a key milestone for Antibodies.com” said Sebastian Newlove, co-founder of Antibodies.com & former bench scientist. “We bootstrapped Antibodies.com from inception and accomplished a great deal of product validation, market traction, and growth. This pre-seed round enables us to significantly expand our operations and will help us achieve our vision of helping researchers discover more, for less”

Paul Carter, senior procurement officer, commented “The University of Manchester is delighted to welcome Antibodies.com as a life science research tool supplier. Their wide range of low cost and high quality reagents will really help support our research”.

About Antibodies.com:
Antibodies.com is a digital marketplace that enables life scientists to purchase cost-effective & validated antibodies, proteins, and immunoassays directly from the primary manufacturers. Headquartered in Cambridge (UK), we serve life scientists worldwide; helping accelerate our understanding of biology and the causes of disease.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...

Cantex and Headlamp Target MS Depression Using Lumos AI

Cantex Pharmaceuticals and Headlamp Health have entered a collaboration...

VoxCell and adMare Partner on Antibody Therapy Research

VoxCell BioInnovation Inc. and adMare BioInnovations have entered a...

Avenda Health Expands Unfold AI Into Midwest Cancer Care

Avenda Health said the University of Michigan Health Weiser...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »